NEW YORK, Jan. 12, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Pioneer Natural Resources (NYSE: PXD)

Pioneer Natural Resources has agreed to merge with Exxon Mobil. Under the proposed transaction Pioneer Natural Resources shareholders will receive $253.00 in cash per share.

  • ImmunoGen, Inc. (Nasdaq: IMGN)

ImmunoGen has agreed to be acquired by AbbVie for $31.26 per share in cash, amounting to an estimated total equity value of $10.1 billion.

  • Hawaiian Holdings, Inc. (Nasdaq: HA)

Hawaiian Holdings, Inc. has agreed to merge with Alaska Air Group. Under the agreement, shareholders of Hawaiian Airlines are set to receive $18.00 per share in cash, valuing the transaction at around $1.9 billion.

  • Icosavax, Inc. (Nasdaq: ICVX)

According to the agreement terms, AstraZeneca will, via a subsidiary, start a tender offer to purchase all outstanding shares of Icosavax for $15.00 per share in cash. Additionally, shareholders will receive a non-tradable contingent value right for up to $5.00 in cash.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-pxd-imgn-ha-and-icvx-investors-to-contact-law-firm-302033722.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

ImmunoGen (NASDAQ:IMGN)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse ImmunoGen
ImmunoGen (NASDAQ:IMGN)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse ImmunoGen